Tizanidine Hydrochloride
Product Images NDC 42291-810

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 42291-810). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemicalstructure (Chemical Structure)

Chemical structure of tizanidine hydrochloride, showing its atomic bonds and molecular arrangement with chlorine, nitrogen, sulfur, and hydrogen atoms.*

FDA Label Image

Figure2 (Figure 2)

A line graph depicting improvement in Ashworth Score over time (hours post-dose) comparing placebo, 8 mg tizanidine, and 16 mg tizanidine doses. The graph shows scores from 0 to 6 hours with plotted lines and error bars, illustrating greater improvement for 16 mg and 8 mg tizanidine compared to placebo.*

FDA Label Image

Figure3 (Figure 3)

A plot showing improvement in Ashworth Score over time comparing tizanidine (mean dose 28.8 mg) and placebo. Data points with error bars are displayed at study week 3 (end of titration), week 7 (end of maintenance), and at the final endpoint. Tizanidine shows greater improvement compared to placebo at all time points.*

FDA Label Image

Figure1 (Figure1)

A line graph showing plasma tizanidine concentration (ng/mL) over time in hours from dosing for 4 mg Tizanidine tablets and capsules taken with and without food. The graph plots four curves comparing the pharmacokinetics of the different formulations under fed and fasting conditions.*

FDA Label Image

Label 4229181015 Tizanidine Hci 2016 2mg

Tizanidine Hydrochloride Capsules 2 mg by AvKARE. The label indicates the package contains 150 capsules. It features a warning stating the product is not interchangeable with tizanidine tablets or Zanaflex. Additional labeling information regarding dosage, storage, and tamper-evident packaging is partially visible.*

FDA Label Image

Label 4229181115 Tizanidine Hci 2018 4mg

Tizanidine Hydrochloride Capsules 4 mg by AvKARE. The label displays the proprietary name and strength, states the NDC 42291-811-15, and indicates that the package contains 150 capsules for Rx only. It includes storage instructions, manufacturer and distributor information, and a warning not to interchange with tizanidine tablets or Zanaflex. The label also has a barcode and a lot number area.*

FDA Label Image

Label 4229181215 Tizanidine 2019 6mg

The packaging label for Tizanidine Hydrochloride Capsules by AvKARE displays the active ingredient strength as 6 mg per capsule. It includes warnings not to interchange with tizanidine tablets or Zanaflex tablets. The label shows a red and white color scheme with dosage instructions, storage conditions, and manufacturer details. The package contains 150 capsules and is marked Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.